Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
73
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
TransMedics Group
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Cost Pressures And Supply Risks Will Weaken Transplant Market Viability
Key Takeaways Greater emphasis on preventive care and new therapies threaten future demand and technological relevance for the company's solutions. High costs, tightening healthcare budgets, and global risks may put ongoing pressure on margins, growth, and profitability.
View narrative
US$114.00
FV
0.4% overvalued
intrinsic discount
17.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Pegasystems
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Low-Code Automation And Hyperscaler Alliances Will Erode Margins
Key Takeaways Rising competitive pressure and market shifts threaten Pegasystems' revenue growth, margins, and pricing power, due to new entrants and bundled solutions from larger rivals. Increasing reliance on subscription SaaS, complex deal structures, and the risk of client consolidation may create revenue volatility and reduce future earnings visibility.
View narrative
US$43.64
FV
17.4% overvalued
intrinsic discount
3.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Cleveland-Cliffs
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Aging Assets And Global Overcapacity Will Crush Steel Margins
Key Takeaways Structural shifts toward steel recycling and decarbonization threaten core demand and pricing power, tightening revenue streams and margins. High capital demands, reliance on legacy assets, and industry disruption risk compressing profitability even as optimization benefits plateau.
View narrative
US$6.01
FV
59.1% overvalued
intrinsic discount
4.69%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
1 day ago
author updated this narrative
SiteOne Landscape Supply
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Urban Sprawl And Water Restrictions Will Disrupt Traditional Landscaping
Key Takeaways Shifting market preferences, regulatory pressures, and urbanization trends threaten demand for traditional landscaping products and challenge long-term revenue growth. Intensifying competition and technological disruption may erode margins, limit acquisition opportunities, and diminish SiteOne's role in the supply chain.
View narrative
US$111.22
FV
19.0% overvalued
intrinsic discount
3.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Civitas Resources
AN
AnalystLowTarget
Consensus Narrative from 14 Analysts
Decarbonization Will Erode Margins Amid DJ Basin Risks
Key Takeaways Ongoing energy transition and stricter environmental regulations threaten long-term revenue growth, market share, and earnings stability for Civitas Resources. Rising compliance and operational costs, geographic concentration risks, and elevated capital constraints may limit shareholder returns and future expansion capacity.
View narrative
US$30.00
FV
0.9% overvalued
intrinsic discount
-3.27%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Robert Half
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Remote Work And AI Will Dismantle Obsolete Staffing Models
Key Takeaways Advances in automation, AI, and freelance platforms threaten Robert Half's traditional staffing model, risking ongoing revenue decline and reducing client and candidate pool relevance. Elevated operating costs and limited pricing power amid flat growth challenge profit margins, as transactional business dependency increases exposure to market volatility and technological disruption.
View narrative
US$33.00
FV
3.6% overvalued
intrinsic discount
1.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Darling Ingredients
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Regulatory Pressures Will Constrain Margins Yet Opportunity Persists
Key Takeaways Regulatory uncertainty and compliance costs threaten profit margins and growth, despite favorable trends supporting renewable fuels and waste upcycling. Diversification into new products and global expansion face risks from market acceptance, competition for inputs, and execution challenges, which could limit long-term gains.
View narrative
US$34.00
FV
9.9% undervalued
intrinsic discount
3.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Science Applications International
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Government Contract Shifts Will Compound Uncertainty And Open IT Opportunities
Key Takeaways Dynamic government procurement and contract changes could risk revenue growth, compress margins, and increase exposure. Loss of key NASA program and shifting government priorities may pressure future revenue and earnings.
View narrative
US$102.00
FV
14.4% overvalued
intrinsic discount
-0.033%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Freshpet
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Slowing Household Formation And Rising Costs Will Weaken Pet Prospects
Key Takeaways Weakening pet adoption trends and consumer trade-down are suppressing Freshpet's growth prospects and limiting its path to higher revenues. Reliance on costly supply chains and regulatory risks threaten profitability, while rising competition undermines pricing power and market share.
View narrative
US$65.00
FV
3.5% undervalued
intrinsic discount
11.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Value any company in seconds
Popular companies